Lithuania: A Global Leader in Stem Cell Research

Vilnius, Lithuania – October 2024 – Lithuania’s reputation as a hub for advanced biomedical research has been further cemented by RBT’s success in developing and deploying novel stem cell therapies. The country’s regulatory excellence and state-of-the-art facilities have enabled RBT to position itself at the forefront of regenerative medicine.

Dr. Darinskas, a pioneer in the field, has been instrumental in establishing Lithuania as a key player in stem cell research, particularly with mesenchymal stem cell (MSC) and exosome therapies. These therapies are now being used to treat a range of conditions, including autoimmune diseases and orthopaedic injuries.